Compare
Abbott Laboratories vs GE HealthCare (ABT vs GEHC)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Abbott Laboratories (ABT) returned -11.7% and GE HealthCare (GEHC) +8.9%; so far this year the figures are -12.3% and +0.4%.
Abbott Laboratories is the larger company by market value, about 5.1 times the size of GE HealthCare.
On trailing earnings, ABT trades at 40.9 times and GEHC at 17.4 times.
Revenue grew +10.0% at ABT and +6.9% at GEHC over the last year.
ABT yields 2.29%. GEHC yields 0.18%.
Data as of the latest close. Not investment advice.
Relative performance
| ABT | GEHC | |
|---|---|---|
| Price | $109.93 | $82.38 |
| 1-day | -3.23% | -1.64% |
| YTD | -12.26% | +0.44% |
| 1 year | -11.73% | +8.95% |
| 3 years | +15.70% | +20.65% |
| Market cap | $190.4B | $37.2B |
| P/E | 40.9 | 17.4 |
| P/S | 3.95 | 1.72 |
| P/B | 3.73 | 3.21 |
| Revenue growth | +10.00% | +6.90% |
| EPS growth | -66.20% | -2.10% |
| Gross margin % | 56.9 | 39.9 |
| Net margin % | 9.7 | 10.0 |
| ROE % | 9.2 | 18.5 |
| Debt / equity | 0.61 | 0.86 |
| FCF yield % | 3.5 | 5.1 |
| Dividend yield % | 2.29 | 0.18 |
| Beta | 0.06 | 0.67 |
| RSI (14) | 58.5 | 71.8 |
| Technical rating |